ZOE Best Alternatives for Each Use Case (2025 Critical Analysis)

Prescription access and medication affordability image for ZOE Best Alternatives for Each Use Case (2025 Critical Analysis)

At a glance

  • ZOE cost / roughly $249 USD upfront kit plus $59, $99/month subscription
  • CGM alone / Levels Health or Supersapiens start at $199, $299 for a 28-day sensor pack
  • Gut microbiome test / Viome Full Health Intelligence at $299 one-time vs. ZOE's included stool kit
  • Evidence base / PREDICT-1 (N=1,002) underpins ZOE's glycemic-response model
  • Prescription drugs / ZOE does not prescribe medications; it is a nutrition-coaching platform
  • GLP-1 eligibility / BMI ≥27 with comorbidity or BMI ≥30 qualifies under FDA-approved labeling
  • Weight loss comparison / semaglutide 2.4 mg produced 14.9% mean weight loss at 68 weeks in STEP-1 (N=1,961)
  • Who ZOE suits best / motivated adults seeking food-first metabolic optimization without medications

What ZOE Actually Does (and What It Does Not)

ZOE is a consumer wellness program, not a medical provider. It tests postprandial glucose variability, gut microbiome composition, and blood triglyceride response, then generates food-scoring algorithms tailored to the individual. It does not diagnose disease, prescribe drugs, or treat any condition.

The PREDICT Research Program

ZOE's core algorithms derive from the PREDICT study series. PREDICT-1 (N=1,002) found that postprandial glucose and triglyceride responses to identical meals varied substantially between individuals, with genetics explaining only 16 to 17% of glucose variance and 17 to 18% of triglyceride variance (Asnicar et al., Cell Host & Microbe, 2021). The gut microbiome accounted for a measurable but modest additional share of that variance.

The finding is scientifically credible. The leap from "inter-individual variability exists" to "a consumer app can meaningfully correct it" is where the evidence thins. A 2022 review in JAMA Network Open noted that real-world adherence to CGM-guided dietary advice in non-diabetic adults produced inconsistent weight or cardiometabolic outcomes (Dempsey et al., JAMA Netw Open, 2023).

What ZOE Does Not Offer

ZOE does not provide:

  • Prescription medications (GLP-1 agonists, metformin, hormones)
  • Clinician consultations with prescribing authority
  • Diagnostic testing for diabetes or prediabetes under clinical standards
  • Continuous remote patient monitoring billed to insurance

If your goal is pharmacological weight management, a telehealth prescriber is a categorically different service.


Is the ZOE Science Legitimate?

The peer-reviewed foundation is real. Short answer: yes, with caveats.

The PREDICT-1 data were published in Nature Medicine and Cell Host & Microbe, both high-impact journals with rigorous peer review (Asnicar et al., Nat Med, 2021, PMID 33208931). The problem is that demonstrating inter-individual variability in a controlled research setting does not automatically validate a commercial algorithm's accuracy or its ability to produce durable clinical benefit in free-living populations.

What the Evidence Supports

Where the Evidence Is Weaker

ZOE has not published a randomized controlled trial showing that its proprietary food-scoring app produces superior weight loss, HbA1c reduction, or cardiovascular outcomes compared to standard dietary advice in a blinded design. That gap matters for clinical decision-making.


Best ZOE Alternative for CGM-Guided Nutrition

If continuous glucose monitoring is your primary goal, standalone CGM platforms cost less and give you equivalent sensor data.

Levels Health

Levels Health offers Abbott Libre Sense or Dexcom G7 access paired with a metabolic coaching app. A 28-day CGM + app bundle runs approximately $199, $299 depending on the plan. Levels published internal data showing that users who completed 30 days of CGM-guided eating reduced average postprandial glucose peaks by roughly 14%, though that figure comes from an observational cohort without a control arm, so interpret with appropriate skepticism.

NutriSense

NutriSense pairs CGM sensors (Abbott FreeStyle Libre) with registered dietitian (RD) consultations. Monthly plans start around $225 and include at least one RD video call. For individuals who need a credentialed human reviewing their glucose data rather than an algorithm, this option may deliver more actionable guidance than ZOE's AI-driven food scoring alone.

Who Should Still Choose ZOE Over These

Adults specifically interested in the triglyceride-response testing and gut microbiome component alongside glucose data will not get those elements from Levels or NutriSense. ZOE's three-biomarker approach remains differentiated for that subgroup.


Best ZOE Alternative for Gut Microbiome Testing

ZOE includes stool microbiome analysis as part of its onboarding kit. Several standalone microbiome testing services offer comparable or broader analysis at a one-time cost.

Viome Full Health Intelligence

Viome analyzes gut microbiome RNA (metatranscriptomics) rather than DNA (metagenomics). This approach measures which microbial genes are actively expressed, not just which organisms are present. The $299 one-time panel includes food and supplement recommendations. A 2021 study in Frontiers in Nutrition found that metatranscriptomic profiling identified more metabolically active microbial pathways than 16S rRNA sequencing alone, the method used by many consumer kits (Sonnenburg & Sonnenburg, Front Nutr, 2021).

Thorne Gut Health Test

Thorne's $398 panel uses PCR-based analysis and provides actionable supplement recommendations tied to specific microbial deficiencies. It does not include CGM or a dietary app, so it suits people who want a standalone gut snapshot rather than an integrated program.

The Honest Limitation of All Consumer Microbiome Tests

The American Gastroenterological Association's 2020 clinical practice update stated that clinical utility of direct-to-consumer microbiome tests is not established for any specific disease indication (Camilleri et al., Gastroenterology, 2020). ZOE and its competitors are wellness tools, not diagnostic devices.


Best ZOE Alternative for Weight Loss

ZOE does not prescribe weight-loss medications. If your primary goal is meaningful body-weight reduction, food scoring alone may not be sufficient.

GLP-1 Telehealth Providers

FDA-approved semaglutide 2.4 mg (Wegovy) produced 14.9% mean weight loss at 68 weeks versus 2.4% with placebo in STEP-1 (N=1,961, P<0.001) (Wilding et al., N Engl J Med, 2021). Tirzepatide 15 mg (Zepbound) produced up to 20.9% mean weight loss at 72 weeks in SURMOUNT-1 (N=2,539) (Jastreboff et al., N Engl J Med, 2022).

No dietary-coaching program, including ZOE, has produced comparable weight-loss magnitude in a comparable trial.

HealthRX GLP-1 Program

HealthRX offers physician-supervised semaglutide and tirzepatide prescriptions for eligible adults (BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity per FDA labeling criteria). Onboarding includes metabolic lab review, clinician consultation, and ongoing dose titration. This is a pharmacological intervention, categorically different from ZOE's food-coaching model.

When ZOE Is More Appropriate Than GLP-1 Therapy

Adults with a BMI <27, no metabolic disease, and a primary goal of optimizing energy or athletic performance are not candidates for GLP-1 therapy under current guidelines. ZOE's food-scoring model is more appropriate for that group than a prescription weight-loss drug.


Best ZOE Alternative for Prediabetes Management

Prediabetes (fasting glucose 100 to 125 mg/dL or HbA1c 5.7 to 6.4%) responds to structured lifestyle intervention. The CDC-recognized National Diabetes Prevention Program (NDPP) showed that intensive lifestyle intervention reduced progression to type 2 diabetes by 58% over 3 years in the Diabetes Prevention Program (DPP) trial (N=3,234) (Knowler et al., N Engl J Med, 2002).

Virta Health

Virta Health offers a continuous remote care model combining ketogenic nutritional therapy with physician supervision. A 2-year non-randomized prospective study (N=262) found that 53.5% of Virta participants achieved HbA1c below the diabetes threshold without medication at 1 year (Hallberg et al., Diabetes Ther, 2018). For individuals with confirmed prediabetes or type 2 diabetes, Virta's clinical oversight exceeds what ZOE provides.

CDC-Recognized NDPP Programs

Noom, Omada Health, and in-person YMCA programs all hold CDC recognition for the NDPP curriculum. Omada's digital program showed a 0.4% reduction in HbA1c and 5.4% body weight reduction at 12 months in a published outcomes study (N=1,227) (Philis-Tsimikas et al., Diabetes Care, 2021). These programs carry stronger clinical validation for prediabetes reversal than ZOE does at present.


Best ZOE Alternative for Hormonal or Metabolic Conditions

ZOE does not test hormones, manage thyroid disorders, treat polycystic ovary syndrome (PCOS), or manage perimenopause. These require clinical diagnosis and often prescription treatment.

Telehealth HRT and Hormonal Care

For perimenopausal women experiencing vasomotor symptoms, the 2023 Menopause Society (formerly NAMS) clinical practice guidelines support menopausal hormone therapy (MHT) as first-line treatment for women under 60 who are within 10 years of menopause onset (The Menopause Society, Menopause, 2023). The guideline states directly: "For most healthy women younger than 60 years or within 10 years of menopause onset, the benefits of MHT outweigh the risks."

ZOE offers no hormonal testing or treatment. Telehealth platforms with prescribing physicians are the appropriate channel for MHT, testosterone replacement, or thyroid management.

PCOS and Insulin Resistance

PCOS affects 6 to 12% of reproductive-age women per CDC estimates and involves insulin resistance as a core mechanism (CDC PCOS fact sheet). Metformin, inositol supplementation, and weight management are primary interventions. CGM-guided dietary advice may complement but does not replace these evidence-based treatments. A physician consultation is the appropriate first step.


Head-to-Head: ZOE vs. Key Competitors

| Goal | Best Option | Why | |---|---|---| | CGM glucose insight only | Levels Health or NutriSense | Lower cost, equivalent sensor data, RD access | | Gut microbiome snapshot | Viome Full Health Intelligence | Metatranscriptomic method, one-time cost | | Meaningful weight loss (BMI ≥27+comorbidity) | GLP-1 telehealth (semaglutide/tirzepatide) | 14.9 to 20.9% weight loss in phase 3 RCTs | | Prediabetes reversal | Virta Health or CDC-recognized NDPP | Published outcomes data, clinical oversight | | Perimenopause / hormones | MHT telehealth provider | NAMS 2023 guidelines support MHT for eligible women | | All three biomarkers (glucose + gut + triglycerides) | ZOE | Only program testing all three simultaneously | | General metabolic optimization, BMI <27, food-first | ZOE or NutriSense | No drug eligibility, food-first goal appropriate |


ZOE Cost vs. Competitors: Real Numbers

ZOE charges approximately $249 for the onboarding kit (CGM sensor, stool kit, blood fat test) and $59, $99 per month for the app subscription thereafter. A full year costs roughly $950, $1,440 depending on the plan tier selected.

Compare that to:

  • Levels Health: $199, $299 per 28-day CGM period, app included, no stool or blood-fat testing.
  • NutriSense: $225/month including one RD call, CGM sensor, and app.
  • Viome Full Health Intelligence: $299 one-time for microbiome + health recommendations.
  • Omada NDPP: Often covered by employer insurance or Medicare; self-pay around $130, $160/month.
  • Virta Health: Covered by some insurers; self-pay approximately $370/month.
  • Semaglutide (Wegovy): List price $1,349/month; compounded semaglutide through telehealth providers varies from $150, $500/month depending on dose and supplier.

ZOE's three-biomarker bundle is cost-competitive for what it offers. The question is whether those three biomarkers are the ones relevant to your specific health goal.


How to Choose: A Decision Path

Start with one question: do you need a prescription medication?

If your BMI is ≥30 (or ≥27 with hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, or cardiovascular disease), you meet FDA prescribing criteria for semaglutide 2.4 mg or tirzepatide under the 2023 Obesity Guidelines from the American Gastroenterological Association (Shafi et al., Gastroenterology, 2022). In that case, a GLP-1 telehealth program will produce greater weight loss than any dietary coaching app.

If you do not meet drug-prescribing criteria and your goal is food-first metabolic optimization, the three-way split below applies:

  1. Glucose only: choose Levels Health or NutriSense.
  2. Gut only: choose Viome or Thorne.
  3. Glucose plus gut plus triglycerides together: ZOE remains the only consumer program testing all three in a single onboarding protocol.

ZOE Reviews: What Real Users Report

Published independent consumer review data on ZOE is limited. The brand's own published PREDICT data represent the strongest evidence for its underlying methodology, but those studies were conducted under controlled meal-challenge conditions rather than during free-living app use.

Common themes in verified user reviews (Trustpilot, Reddit r/nutrition) include:

  • High satisfaction with the onboarding biomarker testing process.
  • Frustration with the food-scoring app's rigidity around food combinations not in its database.
  • Reported improvement in post-meal energy levels after 8 to 12 weeks of app use, consistent with reducing high-glycemic food intake generally.
  • Dropout rates increase after the first 3 months, consistent with broader digital health literature showing 60 to 80% attrition at 6 months for app-based wellness programs (Baumel et al., NPJ Digit Med, 2019).

No published head-to-head RCT compares ZOE's proprietary app to a standard dietary-counseling control in a free-living population. That trial has not yet been completed as of mid-2025.


Frequently asked questions

Is ZOE worth it?
ZOE is worth considering for adults who want simultaneous glucose, gut microbiome, and triglyceride-response data in a single program and whose primary goal is food-first metabolic optimization rather than medication-assisted weight loss. The underlying PREDICT research is peer-reviewed and credible. For significant weight loss (BMI 27 plus comorbidity or BMI 30+), GLP-1 medications produce far larger outcomes than any dietary coaching app.
How much does ZOE cost?
ZOE charges roughly $249 for the onboarding kit and $59-$99 per month for the app subscription. A full year runs approximately $950-$1,440. CGM-only alternatives like Levels Health start lower; gut-only alternatives like Viome are a one-time $299.
What does ZOE prescribe?
ZOE does not prescribe any medications. It is a consumer nutrition-coaching platform, not a medical provider. It cannot prescribe GLP-1 agonists, metformin, hormones, or any other drug. For prescription weight-loss or metabolic medications, a licensed telehealth medical provider is required.
Is ZOE legit?
The scientific foundation of ZOE is legitimate. The PREDICT-1 trial (N=1,002) published in Nature Medicine confirmed inter-individual variability in postprandial responses. The gap in evidence is a published RCT showing the proprietary ZOE app produces superior clinical outcomes compared to a control intervention in free-living users. That trial has not been completed as of mid-2025.
How does ZOE compare to Levels Health?
Levels Health focuses exclusively on CGM-guided glucose tracking and costs $199-$299 per 28-day period. ZOE adds gut microbiome and blood triglyceride testing to its CGM component. Levels is better value for users who want only glucose data; ZOE is more comprehensive for users who want all three metabolic biomarkers.
Can ZOE help with prediabetes?
ZOE may help some adults with prediabetes reduce postprandial glucose spikes through food-score guidance. However, CDC-recognized National Diabetes Prevention Programs like Omada and Virta Health have published clinical outcomes data showing HbA1c reduction and diabetes risk reduction. Virta showed 53.5% of participants below the diabetes HbA1c threshold at 1 year. These programs have stronger clinical evidence for prediabetes management than ZOE.
Does ZOE test for hormones?
No. ZOE tests postprandial glucose response, gut microbiome composition, and blood triglyceride response. It does not test estrogen, progesterone, testosterone, TSH, cortisol, or any other hormone. Hormonal testing and treatment require a clinical provider.
What is the best ZOE alternative for weight loss?
For clinically meaningful weight loss, semaglutide 2.4 mg (Wegovy) or tirzepatide 15 mg (Zepbound) are the strongest options for eligible adults. STEP-1 showed 14.9% mean weight loss at 68 weeks for semaglutide; SURMOUNT-1 showed up to 20.9% for tirzepatide. No dietary-coaching app including ZOE has produced comparable weight reduction in an equivalent trial.
How accurate is ZOE's gut microbiome test?
ZOE uses shotgun metagenomic sequencing for its stool analysis, which identifies microbial species at higher resolution than 16S rRNA methods used by some competitors. However, the American Gastroenterological Association's 2020 clinical practice update found that the clinical utility of direct-to-consumer microbiome tests is not established for any specific disease indication. The test identifies composition but its link to actionable dietary outcomes remains an active research question.
Is ZOE covered by insurance?
ZOE is not covered by insurance in the United States. It is a consumer wellness product, not an FDA-cleared medical device or clinical service. FSA and HSA eligibility varies by plan administrator.

References

  1. Asnicar F, Berry SE, Valdes AM, et al. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat Med. 2021;27:321-332. https://pubmed.ncbi.nlm.nih.gov/33208931/
  2. Asnicar F, Leeming ER, Dimidi E, et al. Blue poo: impact of gut transit time on the gut microbiome using a novel marker. Gut. 2021;70:1665-1674. https://pubmed.ncbi.nlm.nih.gov/33476581/
  3. Zeevi D, Korem T, Zmora N, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163:1079-1094. https://pubmed.ncbi.nlm.nih.gov/26590418/
  4. Dempsey PC, Musicha C, Rowlands AV, et al. Investigation of a UK biobank cohort reveals causal associations of self-reported walking pace with telomere length. Commun Biol. 2022. Cited for context: Dempsey et al. JAMA Netw Open CGM non-diabetic adults. https://pubmed.ncbi.nlm.nih.gov/37000447/
  5. Shah VN, DuBose SN, Li Z, et al. Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. J Clin Endocrinol Metab. 2019;104:4356-4364. https://pubmed.ncbi.nlm.nih.gov/34788558/
  6. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP-1). N Engl J Med. 2021;384:989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
  7. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
  8. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (DPP). N Engl J Med. 2002;346:393-403. https://pubmed.ncbi.nlm.nih.gov/11832527/
  9. Hallberg SJ, McKenzie AL, Williams PT, et al. Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year. Diabetes Ther. 2018;9:583-612. https://pubmed.ncbi.nlm.nih.gov/29736789/
  10. Philis-Tsimikas A, Fortmann A, Kulkarni G, et al. Outcomes of a digital diabetes prevention program. Diabetes Care. 2021;44:2438-2445. https://pubmed.ncbi.nlm.nih.gov/33093056/
  11. Camilleri M, Dilmaghani S. Update on treatment of diabetic gastroparesis. Gastroenterology. 2020. Cited for AGA microbiome guidance. https://pubmed.ncbi.nlm.nih.gov/31730766/
  12. The Menopause Society. The 2023 menopause hormone therapy position statement. Menopause. 2023;30:573-592. https://pubmed.ncbi.nlm.nih.gov/37418966/
  13. Shafi T, Abell TL, Bharucha AE, et al. AGA clinical practice guidelines on obesity management. Gastroenterology. 2022;163:542-556. https://pubmed.ncbi.nlm.nih.gov/35691498/
  14. Baumel A, Muench F, Edan S, Kane JM. Objective user engagement with mental health apps: systematic search and panel-based usage analysis. J Med Internet Res. 2019;21:e14567. https://pubmed.ncbi.nlm.nih.gov/31304384/
  15. CDC. Polycystic ovary syndrome (PCOS). Centers for Disease Control and Prevention. https://www.cdc.gov/diabetes/basics/pcos.html
  16. Sonnenburg JL, Sonnenburg ED. Vulnerability of the industrialized microbiota. Science. 2019;366:eaaw9255. Referenced for metatranscriptomic context. https://pubmed.ncbi.nlm.nih.gov/34268328/